1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. New Jersey >
  6. Citius Pharmaceuticals Acquires Leonard-Meron Biosciences

M&A Deal Summary

Citius Pharmaceuticals Acquires Leonard-Meron Biosciences

On March 7, 2016, Citius Pharmaceuticals acquired life science company Leonard-Meron Biosciences

Acquisition Highlights
  • This is Citius Pharmaceuticals’ 1st transaction in the Life Science sector.
  • This is Citius Pharmaceuticals’ 1st transaction in the United States.
  • This is Citius Pharmaceuticals’ 1st transaction in New Jersey.

M&A Deal Summary
Date 2016-03-07
Target Leonard-Meron Biosciences
Sector Life Science
Buyer(s) Citius Pharmaceuticals
Deal Type Add-on Acquisition

Target

Leonard-Meron Biosciences

Cranford, New Jersey, United States
Leonard Meron Biosciences, Inc. (LMB) is a private, late-stage specialty pharmaceutical company focused on the development and commercialization of critical care products with a concentration on anti-infective drugs. The Company is developing Mino-Lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, or CRBSIs.

Search 214,600 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Citius Pharmaceuticals

Maynard, Massachusetts, United States
Category Company
Founded 2007
Sector Life Science
DESCRIPTION

Citius Pharmaceuticals, Inc. is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for large and growing markets using innovative, patented or proprietary formulations of previously approved pharmaceutical products.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: New Jersey M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2016 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal